litlas
ログインアカウント作成

Andrew Briggs

1994–2025 年に発表

147
論文数
39,567
被引用数
93
h 指数
144
i10 指数

被引用数

Andrew Briggs の年別被引用数1928 年: 被引用 1 件1977 年: 被引用 1 件1987 年: 被引用 1 件1993 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 3 件1997 年: 被引用 7 件1998 年: 被引用 17 件1999 年: 被引用 22 件2000 年: 被引用 36 件2001 年: 被引用 40 件2002 年: 被引用 56 件2003 年: 被引用 71 件2004 年: 被引用 114 件2005 年: 被引用 128 件2006 年: 被引用 147 件2007 年: 被引用 107 件2008 年: 被引用 118 件2009 年: 被引用 142 件2010 年: 被引用 131 件2011 年: 被引用 141 件2012 年: 被引用 173 件2013 年: 被引用 183 件2014 年: 被引用 192 件2015 年: 被引用 228 件2016 年: 被引用 218 件2017 年: 被引用 223 件2018 年: 被引用 230 件2019 年: 被引用 1,057 件2020 年: 被引用 1,178 件2021 年: 被引用 998 件2022 年: 被引用 793 件2023 年: 被引用 558 件2024 年: 被引用 963 件2025 年: 被引用 348 件2026 年: 被引用 13 件1929〜1976 年は被引用が無いため表示していません1978〜1986 年は被引用が無いため表示していません1988〜1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図イギリス: 引用元論文 2,546 件、この内訳の 16.8%アメリカ合衆国: 引用元論文 2,480 件、この内訳の 16.3%オーストラリア: 引用元論文 865 件、この内訳の 5.7%カナダ: 引用元論文 816 件、この内訳の 5.4%オランダ: 引用元論文 797 件、この内訳の 5.2%ドイツ: 引用元論文 642 件、この内訳の 4.2%中国: 引用元論文 497 件、この内訳の 3.3%スペイン: 引用元論文 453 件、この内訳の 3%イタリア: 引用元論文 451 件、この内訳の 3%フランス: 引用元論文 439 件、この内訳の 2.9%スイス: 引用元論文 402 件、この内訳の 2.6%スウェーデン: 引用元論文 330 件、この内訳の 2.2%
0%16.8%その他 29.4%

機関

分野

  • Medicine67.5%
  • Economics, Econometrics and Finance9.5%
  • Health Professions5.1%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Psychology3.1%
  • Computer Science1.6%
  • その他10%

トピック

  • Health Systems, Economic Evaluations, Quality of Life5.2%
  • Asthma and respiratory diseases1.4%
  • Healthcare cost, quality, practices1.1%
  • Long-Term Effects of COVID-191%
  • Diabetes Treatment and Management1%
  • Acute Myocardial Infarction Research0.9%
  • その他89.4%

共著者

全論文

検索で開く
  1. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

    著者: Don Husereau, Michael Drummond, Federico Augustovski, Esther W. de Bekker‐Grob, Andrew Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh‐Fang Pwu, Sophie Staniszewska - Value in Health 2022 被引用: 830

  2. Oral versus Intravenous Antibiotics for Bone and Joint Infection

    著者: Ho Kwong Li, Ines Rombach, Rhea Zambellas, A. Sarah Walker, Martin McNally, Bridget L. Atkins, Benjamin A. Lipsky, Harriet Hughes, Deepa Bose, Michelle Kümin, Claire Scarborough, Philippa C. Matthews, Andrew Brent, José Manuel Lomas, Roger Gundle, M. Rogers, Adrian Taylor, Brian Angus, Ivor Byren, Anthony R. Berendt, Simon Warren, Fiona E. Fitzgerald, Damien Mack, Susan Hopkins, Jonathan Folb, Helen Reynolds, Elinor Moore, Jocelyn R. Marshall, Neil Jenkins, Christopher E. Moran, Andrew Woodhouse, Samantha Stafford, R.A. Seaton, Claire Vallance, Carolyn Hemsley, Karen Bisnauthsing, Jonathan Sandoe, Ila Aggarwal, Simon Ellis, Deborah Bunn, Rebecca Sutherland, Gavin Barlow, Cushla Cooper, Claudia Geue, Nicola McMeekin, Andrew Briggs, Parham Sendi, Elham Khatamzas, Tri Wangrangsimakul, T.H. Nicholas Wong, Lucinda Barrett, Abtin Alvand, ChristopherW. Old, Jennifer Bostock, John R. Paul, Graham Cooke, Guy Thwaites, Philip Bejon, Matthew Scarborough - New England Journal of Medicine 2019 被引用: 900

  3. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    著者: Rachael A Evans, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish McAuley, A Shikotra, Amisha Singapuri, Marco Sereno, Ruth Saunders, Victoria Harris, Linzy Houchen‐Wolloff, Raminder Aul, Paul Beirne, Charlotte E. Bolton, Jeremy Brown, Gourab Choudhury, N Diar-Bakerly, Nicholas Easom, Carlos Echevarria, Jonathan Fuld, Nicholas Hart, John R. Hurst, Mark G. Jones, Dhruv Parekh, Paul Pfeffer, Najib M. Rahman, Sarah Rowland‐Jones, Aarti Shah, Dan Wootton, Trudie Chalder, Matthew Davies, Anthony De Soyza, J R Geddes, William Greenhalf, Neil Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, Gísli Jenkins, Janet M. Lord, William D‐C Man, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Malcolm G. Semple, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Ryan S. Thwaites, Andrew Briggs, Annemarie B Docherty, S Kerr, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, K Poinasamy, Betty Raman, Ewen M. Harrison, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, R Adrego, L A Aguilar Jimenez, Shazaad Ahmad, Nafees Haider, Rizwan Ahmed, N Ahwireng, Mark Ainsworth, B Al-Sheklly, A Alamoudi, Mohammad Ali, M Aljaroof, AM All, Louise Allan, R Allen, L. Allerton, Lynne Allsop, P. Almeida, Doris Altmann, Maria Alvarez Corral, S Amoils, Debra Anderson, Chrystalina A. Antoniades, G Arbane, A. Arias, Chérie Armour ほか 906 名 - The Lancet Respiratory Medicine 2022 被引用: 424

  4. Decision Modelling For Health Economic Evaluation

    著者: Andrew Briggs, Karl Claxton, Mark Sculpher - 2006 被引用: 3,113

  5. Cardiac Troponin T and Troponin I in the General Population

    著者: Paul Welsh, David Preiss, Caroline Hayward, Anoop Shah, David McAllister, Andrew Briggs, Charles Boachie, Alex McConnachie, Sandosh Padmanabhan, Claire Welsh, Mark Woodward, Archie Campbell, David J. Porteous, Nicholas L. Mills, Naveed Sattar - Circulation 2019 被引用: 327

  6. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    著者: Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew Briggs, Josephine Mauskopf, Elizabeth Loder - Value in Health 2013 被引用: 2,058

  7. Model Parameter Estimation and Uncertainty Analysis

    著者: Andrew Briggs, Milton C. Weinstein, Elisabeth Fenwick, Jonathan Karnon, Mark Sculpher, A. David Paltiel - Medical Decision Making 2012 被引用: 886

  8. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

    著者: Richard D Riley, Jill A. Hayden, Ewout W. Steyerberg, Karel G.M. Moons, Keith R. Abrams, P. Kyzas, Núria Malats, Andrew Briggs, Sara Schroter, Douglas G. Altman, Harry Hemingway, for the PROGRESS Group - PLoS Medicine 2013 被引用: 811

  9. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    著者: Don Husereau, Michael Drummond, Federico Augustovski, Esther W. de Bekker‐Grob, Andrew Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh‐Fang Pwu, Sophie Staniszewska - Applied Health Economics and Health Policy 2022 被引用: 997

  10. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

    著者: Harry Hemingway, Peter Croft, Pablo Perel, Jill A. Hayden, Keith R. Abrams, Adam Timmis, Andrew Briggs, Ruzan Udumyan, Karel G.M. Moons, Ewout W. Steyerberg, Ian Roberts, Sara Schroter, Douglas G. Altman, Richard D Riley, for the PROGRESS Group - BMJ 2013 被引用: 674

  11. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

    著者: Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew Briggs, Josephine Mauskopf, Elizabeth Loder, on behalf of the CHEERS Task Force - BMJ 2013 被引用: 1,765

  12. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    著者: J. Jaime, Andrew Briggs, Uwe Siebert, Karen M. Kuntz - Value in Health 2012 被引用: 755

  13. Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    著者: Andrew Briggs, Milton C. Weinstein, Elisabeth Fenwick, Jonathan Karnon, Mark Sculpher, A. David Paltiel - Value in Health 2012 被引用: 703

  14. Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    著者: Scott D. Ramsey, Richard J. Willke, Henry A. Glick, Shelby D. Reed, Federico Augustovski, Bengt Jönsson, Andrew Briggs, Sean D. Sullivan - Value in Health 2015 被引用: 837

  15. Review of statistical methods for analysing healthcare resources and costs

    著者: Borislava Mihaylova, Andrew Briggs, Anthony O’Hagan, Simon G. Thompson - Health Economics 2010 被引用: 773

  16. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia

    著者: Andrew Gumley, Simon Bradstreet, John Ainsworth, Stephanie Allan, Mario Álvarez‐Jiménez, Lorna Aucott, Max Birchwood, Andrew Briggs, Sandra Bucci, Sue Cotton, Lidia Engel, Paul French, Reeva Lederman, Shôn Lewis, Matthew Machin, Graeme MacLennan, Hamish J. McLeod, Nicola McMeekin, Cathy Mihalopoulos, Emma Morton, John Norrie, Matthias Schwannauer, Swaran P. Singh, Suresh Sundram, Andrew Thompson, Chris Williams, Alison R. Yung, John Farhall, John Gleeson - The Lancet Psychiatry 2022 被引用: 72

  17. Modeling Good Research Practices—Overview

    著者: J. Jaime, Andrew Briggs, Uwe Siebert, Karen M. Kuntz - Medical Decision Making 2012 被引用: 511

  18. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

    著者: Oliver Carlile, Andrew Briggs, Alasdair D Henderson, Ben F.C. Butler-Cole, John Tazare, Laurie A. Tomlinson, Michael Marks, Mark Jit, Liang-Yu Lin, Chris Bates, John Parry, Seb Bacon, Iain Dillingham, William A. Dennison, Ruth Costello, Alex J Walker, William Hulme, Ben Goldacre, Amir Mehrkar, Brian MacKenna, Alex Walker, Amelia Green, Amir Mehrkar, Andrea L. Schaffer, A.D. Brown, Ben Goldacre, Ben Butler-Cole, Brian MacKenna, Caroline E Morton, Caroline E. Walters, Catherine L. Stables, Christine Cunningham, Christopher Wood, Colm Andrews, David Evans, George Hickman, Helen J Curtis, Henry Drysdale, Iain Dillingham, Jessica Morley, Jon Massey, Linda Nab, Lisa Hopcroft, Louis Fisher, Lucy Bridges, Milan Wiedemann, Nicholas DeVito, Orla Macdonald, Peter Inglesby, Rebecca Smith, Richard Croker, Robin Park, Rose Higgins, Seb Bacon, Simon Davy, Steven Maude, Thomas O’Dwyer, Tom Ward, Victoria Speed, William Hulme, Liam Hart, Pete Stokes, Krishnan Bhaskaran, Ruth Costello, Thomas E. Cowling, Ian Douglas, Rosalind M. Eggo, Stephen Evans, Harriet Forbes, Richard Grieve, Daniel Grint, Emily Herrett, Sinéad Langan, Viyaasan Mahalingasivam, Kathryn E. Mansfield, Rohini Mathur, Helen McDonald, Edward P K Parker, Christopher T. Rentsch, Anna Schultze, Liam Smeeth, John Tazare, Laurie A. Tomlinson, Jemma Walker, Elizabeth M. Williamson, Kevin Wing, Angel Wong, Bang Zheng, Chris Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Shaun O’Hanlon, Alex Eavis, Richard Jarvis, Dima Avramov, Paul Griffiths, Aaron Fowles, Nasreen Parkes ほか 7 名 - The Lancet Regional Health - Europe 2024 被引用: 96

  19. Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis

    著者: Min Huang, Joyce O’Shaughnessy, Jing Zhao, Amin Haiderali, Javier Cortés, Scott D. Ramsey, Andrew Briggs, Peter Hu, Vassiliki Karantza, Gursel Aktan, Cynthia Z. Qi, Chenyang Gu, Jipan Xie, Muhan Yuan, John S. Cook, Michael Untch, Peter Schmid, Peter A. Fasching - Cancer Research 2020 被引用: 167

  20. An Introduction to Markov Modelling for Economic Evaluation

    著者: Andrew Briggs, Mark Sculpher - PharmacoEconomics 1998 被引用: 960

  21. Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions

    著者: Elisabeth Fenwick, Bernie J. OʼBrien, Andrew Briggs - Health Economics 2004 被引用: 943

  22. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

    著者: Thomas Wilkinson, Mark Sculpher, Karl Claxton, Paul Revill, Andrew Briggs, John Cairns, Yot Teerawattananon, Elias Asfaw, Ruth Lopert, Anthony J. Culyer, Damian Walker - Value in Health 2016 被引用: 346

  23. The Future of Fundamental Science Led by Generative Closed-Loop Artificial Intelligence

    著者: Hector Zenil, Jesper Tegnér, Felipe S. Abrahão, Alexander Lavin, Vipin Kumar, Jeremy G. Frey, Adrian Weller, Larisa N. Soldatova, Alan R. Bundy, Nicholas R. Jennings, Koichi Takahashi, Lawrence Hunter, Saso Dzeroski, Andrew Briggs, Frederick D. Gregory, Carla P. Gomes, Christopher K. I. Williams, Jonathan E. Rowe, James A. Evans, Hiroaki Kitano, Joshua B. Tenenbaum, Ross D. King - Frontiers in Artificial Intelligence, Frontiers Artif. Intell. 2023 被引用: 23

  24. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation

    著者: Andrew Briggs, David Wonderling, Christopher Z. Mooney - Health Economics 1997 被引用: 887